SinoHytec’s 1H 2026: Loss Narrows 36%, Gross Margin Turns Positive on Cost Controls

Bulletin Express
Sep 29

Beijing-based fuel-cell specialist SinoHytec reported first-half 2026 revenue of RMB 73.94 million, edging up 2.80 % year-on-year. Sales of hydrogen fuel-cell systems fell 15.49 % to RMB 42.80 million, but a 72.20 % jump in “other” businesses, including initial energy-storage deliveries, offset the decline.

Gross profit swung to a positive RMB 14.25 million from a RMB 30.15 million loss a year earlier, lifting gross margin to 19.3 % from –41.9 %. Management cited tighter supply-chain coordination, inventory reductions and cost-cutting measures for the turnaround.

Loss attributable to shareholders narrowed to RMB 105.04 million, a 35.70 % improvement versus the RMB 163.35 million shortfall in 1H 2025. Basic loss per share improved to RMB 0.44 from RMB 0.71.

Operating performance reflected muted sector demand: total sales power rose 32.83 % to 21,200 kW, yet unit pricing pressure persisted, with average revenue per kilowatt down 36.38 % to RMB 2.02 thousand.

R&D spending fell 44.64 % to RMB 14.10 million, representing 19.07 % of revenue, as projects were streamlined. The pipeline includes multi-megawatt PEM power systems, high-power engine platforms and electrochemical energy-storage solutions.

Operating cash outflow narrowed to RMB 12.74 million. Cash and cash equivalents stood at RMB 344.42 million at 30 June, while net debt totalled RMB 919.55 million, implying a 49.0 % gearing ratio.

SinoHytec continued diversifying beyond vehicle fuel-cell systems, establishing an energy-storage subsidiary and completing its first equipment deliveries. International expansion progressed with an overseas heavy-duty truck fuel-cell project.

The board declared no interim dividend.

Management flagged risks from policy shifts, industry overcapacity, customer concentration and lingering subsidy collection delays, but reaffirmed its strategy to deepen R&D, broaden application scenarios and strengthen liquidity management.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10